
Please try another search
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company’s products include INGREZZA for tardive dyskinesia and chorea associated with Huntington’s disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia. Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy and schizophrenia; NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia; NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.
Name | Age | Since | Title |
---|---|---|---|
William H. Rastetter | 73 | 2010 | Independent Chairman of the Board |
George J. Morrow | 72 | 2015 | Independent Director |
Christine Ann Poon | 72 | 2023 | Independent Director |
Johanna Mercier | 54 | 2021 | Independent Director |
Richard F. Pops | 62 | 1998 | Independent Director |
Gary A. Lyons | 73 | 1993 | Independent Director |
Stephen A. Sherwin | 75 | 1999 | Independent Director |
Kevin C. Gorman | 66 | 2006 | Director |
Kyle W. Gano | 51 | 2011 | CEO & Director |
Shalini Sharp | 49 | 2020 | Independent Director |
Leslie V. Norwalk | 59 | 2019 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review